ResMed

$183.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$7.16 (-3.76%) Today
$0.00 (0.00%) As of 12:45 AM UTC after-hours

Why Robinhood?

You can buy or sell ResMed and other stocks, options, and ETFs commission-free!

About RMD

ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment engages in the supply of business management software as a service to out-of-hospital health providers. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA. The listed name for RMD is ResMed Inc.

CEO
Michael J. Farrell
Employees
7,770
Headquarters
San Diego, California
Founded
1989
Market Cap
26.58B
Price-Earnings Ratio
40.37
Dividend Yield
0.81
Average Volume
698.79K
High Today
$190.08
Low Today
$181.28
Open Price
$189.30
Volume
984.74K
52 Week High
$224.43
52 Week Low
$108.85

RMD News

MarketWatch3h

ResMed Inc. stock underperforms Thursday when compared to competitors

Shares of ResMed Inc. RMD shed 3.76% to $183.05 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index

RMD Earnings

$0.00
$0.47
$0.94
$1.41
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
per share
Actual
Expected Apr 29, After Hours

You May Also Like

AXAS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure